These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33036052)

  • 1. Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers.
    Stallmach A; Sturm A; Blumenstein I; Helwig U; Koletzko S; Lynen P; Schmidt C; Dignass A; Kucharzik T;
    Z Gastroenterol; 2020 Oct; 58(10):982-1002. PubMed ID: 33036052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers].
    Stallmach A; Sturm A; Blumenstein I; Helwig U; Koletzko S; Lynen P; Schmidt C; Dignaß A; Kucharzik T;
    Z Gastroenterol; 2020 Jul; 58(7):672-692. PubMed ID: 32659830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn's and Colitis Organization.
    D'Amico F; Danese S; Peyrin-Biroulet L;
    Gastroenterology; 2020 Jul; 159(1):14-19.e3. PubMed ID: 32360567
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting.
    Rubin DT; Abreu MT; Rai V; Siegel CA;
    Gastroenterology; 2020 Jul; 159(1):6-13.e6. PubMed ID: 32272113
    [No Abstract]   [Full Text] [Related]  

  • 5. [A surgically relevant summary of the addendum to the S3 guidelines of the DGVS on Crohn's disease and ulcerative colitis : Treatment of chronic inflammatory bowel diseases in the COVID-19 pandemic].
    Grunert PC; Dignass A; Kucharzik T; Stallmach A; Sturm A; Schmidt C
    Chirurg; 2021 Jan; 92(1):30-33. PubMed ID: 33320280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.
    Aysha AA; Rentsch C; Prentice R; Johnson D; Bryant RV; Ward MG; Costello SP; Lewindon P; Ghaly S; Connor SJ; Begun J; Christensen B
    Intern Med J; 2020 Jul; 50(7):798-804. PubMed ID: 32656985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of Endoscopy in Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.
    Navaneethan U; Lourdusamy D; LehnerNoguera V; Shen B
    Inflamm Bowel Dis; 2020 Sep; 26(10):e118-e119. PubMed ID: 32676646
    [No Abstract]   [Full Text] [Related]  

  • 8. Practical advice for management of inflammatory bowel diseases patients during the COVID-19 pandemic: World Endoscopy Organization Statement.
    Neumann H; Emura F; Bokemeyer B; Guda N; Tajiri H; Matsumoto T; Rubin DT
    Dig Endosc; 2020 Jul; 32(5):658-662. PubMed ID: 32369646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients.
    Azzam NA; Aljebreen A; Almuhareb A; Almadi MA
    Saudi J Gastroenterol; 2020; 26(5):256-262. PubMed ID: 32415045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?
    Monteleone G; Ardizzone S
    J Crohns Colitis; 2020 Sep; 14(9):1334-1336. PubMed ID: 32215548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.
    Rubin DT; Feuerstein JD; Wang AY; Cohen RD
    Gastroenterology; 2020 Jul; 159(1):350-357. PubMed ID: 32283100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic.
    Grossberg LB; Pellish RS; Cheifetz AS; Feuerstein JD
    Inflamm Bowel Dis; 2021 May; 27(6):940-946. PubMed ID: 32619010
    [No Abstract]   [Full Text] [Related]  

  • 13. Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel.
    Din S; Kent A; Pollok RC; Meade S; Kennedy NA; Arnott I; Beattie RM; Chua F; Cooney R; Dart RJ; Galloway J; Gaya DR; Ghosh S; Griffiths M; Hancock L; Hansen R; Hart A; Lamb CA; Lees CW; Limdi JK; Lindsay JO; Patel K; Powell N; Murray CD; Probert C; Raine T; Selinger C; Sebastian S; Smith PJ; Tozer P; Ustianowski A; Younge L; Samaan MA; Irving PM
    Gut; 2020 Oct; 69(10):1769-1777. PubMed ID: 32513653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period.
    Iacucci M; Cannatelli R; Labarile N; Mao R; Panaccione R; Danese S; Kochhar GS; Ghosh S; Shen B
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):598-606. PubMed ID: 32305075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020).
    Marín-Jiménez I; Zabana Y; Rodríguez-Lago I; Marín L; Barreiro-de Acosta M; Esteve M;
    Gastroenterol Hepatol; 2020; 43(7):408-413. PubMed ID: 32419715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frequency of COVID-19 in inflammatory bowel diseases.
    Marafini I; Salvatori S; Sena G; Calabrese E; Biancone L; Monteleone G
    Dig Liver Dis; 2020 Nov; 52(11):1234-1235. PubMed ID: 32601036
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD clinics?
    Malickova K; Kratka Z; Luxova S; Bortlik M; Lukas M
    Scand J Gastroenterol; 2020 Aug; 55(8):917-919. PubMed ID: 32663041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of inflammatory bowel diseases in the wake of COVID-19 pandemic.
    Pasha SB; Fatima H; Ghouri YA
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1449-1450. PubMed ID: 32246874
    [No Abstract]   [Full Text] [Related]  

  • 19. The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis.
    Aziz M; Fatima R; Haghbin H; Lee-Smith W; Nawras A
    Inflamm Bowel Dis; 2020 Sep; 26(10):e132-e133. PubMed ID: 32619003
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical Trials for Inflammatory Bowel Disease: Global Guidance During the COVID-19 Pandemic.
    Reinisch W; Danese S; Peyrin-Biroulet L; Loftus EV
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S815-S819. PubMed ID: 32520311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.